Home
Animals
Biology
Environment
Health & Medicine
Tech Travel
Space
Natureworldnews.com
Let's Connect
Trending
climate change
environment
nature
natural disasters
animals
Home
Tag
MT Pharma America
MT Pharma America
Health & Medicine
Newly Approved Drug for ALS 'Radicava' Costs Over $145,000 a Year
By
John Raphael
FDA approves new drug for ALS treatment that costs $145,524 annually.
Latest Research Articles
Email Newsletter
most popular
Tennessee Native Wins Big in Florida’s Battle Against Invasive Pythons
Texas Weather Update: Roads Closed, Houses Submerged As Heavy Rains Hit, Bring Floods
Central US Weather Forecast: Severe Storms to Bring Downpours, Tornado Threats
Thallium Threat: Baltic Sea Faces Toxic Challenge from Human Sources
Venomous Centipede Could be Game-Changer and Save Lives of People with Kidney Disease [Study]